Epstein Secrets

L EMAIL] - FBI Public Affairs News Briefing Friday, October 23, 2020 To: [email protected] Sent: October 23, 2020 6:26 AM (UTC-04:00) Mobile version and searchable archives available at tbi.bulletinintellioence.com. TO : THE DIRECTOR AND SENIOR STAFF DATE : FRIDAY, OCTOBER 23, 20

Efficacy Standards For Vaccine. The Washington Post (10/22, McGinley, Johnson, 14.2M) reports that vaccine experts on Thursday "rigorously debated the Food and Drug Administration's planned standards for clearing a coronavirus vaccine quickly for broad use, discussing what level of evidence would be sufficient to establish safe

ubject: [EXTERNAL EMAIL] - FBI Public Affairs 2020 Date: Fri, 23 Oct 2020 10:26:13 +0000 c Importan e: Normal News Briefing Friday, October 23, Mobile version and searchable archives available at fbi.bulletinintelligence.com. 'FBI News Briefing TO: THE DIRECTOR AND SENIOR STAFF DATE: FRIDAY, OCTOB

Efficacy Standards For Vaccine. The Washington Post (10/22, McGinley, Johnson, 14.2M) reports that vaccine experts on Thursday "rigorously debated the Food and Drug Administration's planned standards for clearing a coronavirus vaccine quickly for broad use, discussing what level of evidence would be sufficient to establish safe

) Eastern Time (US & Canada) To: [email protected] Subject: [EXTERNAL EMAIL] - FBI Public Affairs News Briefing Monday, August 03, 2020 Mobile version and searchable archives available at fbi.bulletinintelligence.com. ; -2 tin News Briefing TO: THE DIRECTOR AND SENIOR STAFF DATE: MONDAY, A

e than 100 products that may contain methanol, which could be toxic when absorbed through skin or ingested." USA Today (8/1, Tyko, 10.31M) reports the Food and Drug Administration's "do-not-use list of dangerous hand sanitizer products" keeps growing, with the list, as of Saturday, now featuring 101 hand sanitizer varieties. Th

tern Time (US & Canada) To: [email protected] Subject: [EXTERNAL EMAIL] - FBI Public Affairs News Briefing Thursday, September 03, 2020 Mobile version and searchable archives available at fbi.bulletinintelligence.com. WIBI News Briefing TO: THE DIRECTOR AND SENIOR STAFF DATE: THURSDAY, SEP

or Efficacy Or Safety Of Convalescent Plasma. In an op-ed for the New York Times (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evidence." Lamas writes that possible treatments must undergo clinical tria